AmCham is a great platform for companies and individuals sharing the same values.
Aigars Milts, Chief Executive Officer of IIZI Brokers
On March, 26 members had an opportunity to join an online briefing on the COVID-19 vaccine with Professor Kaspars Tars, Senior Researcher at the Biomedical Research and Study Center of Latvia.
This online event provided an in-depth discussion about the development and efficacy of the COVID-19 vaccine, including about different vaccine types, how they work and their efficacy against new variants.
About the Speaker:
Prof. Kaspars Tārs is a structural biologist at Latvian Biomedical Research and Study Centre and University of Latvia. His main interests are structure and function of ssRNA bacteriophages and applications of their virus-like particles in vaccine development. Kaspars Tārs has graduated from Riga Technical University and defended his PhD at Uppsala University, Sweden. After 11 years in Sweden, he returned to Latvia in 2007 where he is leading a structural biology and biotechnology group. Kaspars Tārs has published about 100 scientific articles, H-index 27, total number of citations 2258 (Scopus data).
We encourage to send us your questions in advance. Please send them to: email@example.com until the noon on March 25.
Admission: Free for AmCham members, EUR 20 for non-members.
Please register below. You will receive a link shortly before the meeting.
We re-affirm our commitment to the values that AmCham stands for and that we share.
Kārlis Danēvičs, Board member, Head of Credits and Risk at SEB Banka